
Nuclear medicine physicians have suspected since the advent of PET/CT that the hybrid technology would outperform either PET or CT alone for staging cancer. Those suspicions have been confirmed in a study of 260 patients at the University of Essen, Germany. It found that PET/CT is substantially more accurate for staging carcinoma than PET or CT alone and even PET and CT viewed side by side (PET+CT).





















